368 related articles for article (PubMed ID: 32425928)
1. Myeloid-Derived Suppressor Cells in Kidney Transplant Recipients and the Effect of Maintenance Immunotherapy.
Iglesias-Escudero M; Sansegundo-Arribas D; Riquelme P; Merino-Fernández D; Guiral-Foz S; Pérez C; Valero R; Ruiz JC; Rodrigo E; Lamadrid-Perojo P; Hutchinson JA; Ochando J; López-Hoyos M
Front Immunol; 2020; 11():643. PubMed ID: 32425928
[TBL] [Abstract][Full Text] [Related]
2. Early Posttransplant Mobilization of Monocytic Myeloid-derived Suppressor Cell Correlates With Increase in Soluble Immunosuppressive Factors and Predicts Cancer in Kidney Recipients.
Utrero-Rico A; Laguna-Goya R; Cano-Romero F; Chivite-Lacaba M; Gonzalez-Cuadrado C; Rodríguez-Sánchez E; Ruiz-Hurtado G; Serrano A; Fernández-Ruiz M; Justo I; González E; Andrés A; Paz-Artal E
Transplantation; 2020 Dec; 104(12):2599-2608. PubMed ID: 32068661
[TBL] [Abstract][Full Text] [Related]
3. The mTOR Deficiency in Monocytic Myeloid-Derived Suppressor Cells Protects Mouse Cardiac Allografts by Inducing Allograft Tolerance.
Li J; Chen J; Zhang M; Zhang C; Wu R; Yang T; Qiu Y; Liu J; Zhu T; Zhang Y; Rong R
Front Immunol; 2021; 12():661338. PubMed ID: 33897705
[TBL] [Abstract][Full Text] [Related]
4. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
[TBL] [Abstract][Full Text] [Related]
5. Preliminary assessment of the feasibility of autologous myeloid-derived suppressor cell infusion in non-human primate kidney transplantation.
Ezzelarab MB; Perez-Gutierrez A; Humar A; Wijkstrom M; Zahorchak AF; Lu-Casto L; Wang YC; Wiseman RW; Minervini M; Thomson AW
Transpl Immunol; 2019 Oct; 56():101225. PubMed ID: 31330261
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-Derived Suppressor Cells in Lung Transplantation.
Heigl T; Singh A; Saez-Gimenez B; Kaes J; Van Herck A; Sacreas A; Beeckmans H; Vanstapel A; Verleden SE; Van Raemdonck DE; Verleden G; Vanaudenaerde BM; Hartl D; Vos R
Front Immunol; 2019; 10():900. PubMed ID: 31080450
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of High Levels of Monocytic Myeloid-Derived Suppressor Cells Enhances Graft Survival in Almost-Tolerant Kidney Transplant Recipients.
Du XX; Guo YL; Zhao YP; Yang M; Chang S; Liu B; Cai LJ; Chen ZK
Transplant Proc; 2018 Dec; 50(10):3314-3320. PubMed ID: 30577201
[TBL] [Abstract][Full Text] [Related]
8. mTOR inhibitor rapamycin induce polymorphonuclear myeloid-derived suppressor cells mobilization and function in protecting against acute graft-versus-host disease after bone marrow transplantation.
Lin Y; Wang B; Shan W; Tan Y; Feng J; Xu L; Wang L; Han B; Zhang M; Yu J; Yu X; Huang H
Clin Immunol; 2018 Feb; 187():122-131. PubMed ID: 29132870
[TBL] [Abstract][Full Text] [Related]
9. mTOR signaling disruption from myeloid-derived suppressive cells protects against immune-mediated hepatic injury through the HIF1α-dependent glycolytic pathway.
Chen X; Zhang Z; Bi Y; Fu Z; Gong P; Li Y; Yu Q; Jia A; Wang J; Xue L; Yang H; Liu G
J Leukoc Biol; 2016 Dec; 100(6):1349-1362. PubMed ID: 27462101
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin Prolongs Cardiac Allograft Survival in a Mouse Model by Inducing Myeloid-Derived Suppressor Cells.
Nakamura T; Nakao T; Yoshimura N; Ashihara E
Am J Transplant; 2015 Sep; 15(9):2364-77. PubMed ID: 25943210
[TBL] [Abstract][Full Text] [Related]
11. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.
Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S
Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893
[No Abstract] [Full Text] [Related]
12. Persistent accumulation of circulating monocytic myeloid-derived suppressor cells contributes to post-infectious immunosuppression in renal transplant recipients with bacterial infection: A pilot study.
Jiang Y; Feng S; Ji J; Lin Z; Zhang X
Transpl Immunol; 2018 Jun; 48():10-17. PubMed ID: 29477752
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-derived suppressor cells in transplantation tolerance induction.
Cao P; Sun Z; Feng C; Zhang J; Zhang F; Wang W; Zhao Y
Int Immunopharmacol; 2020 Jun; 83():106421. PubMed ID: 32217462
[TBL] [Abstract][Full Text] [Related]
14. mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors.
Wu T; Zhao Y; Wang H; Li Y; Shao L; Wang R; Lu J; Yang Z; Wang J; Zhao Y
Sci Rep; 2016 Feb; 6():20250. PubMed ID: 26833095
[TBL] [Abstract][Full Text] [Related]
15. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer.
Tavukcuoglu E; Horzum U; Yanik H; Uner A; Yoyen-Ermis D; Nural SK; Aydin B; Sokmensuer C; Karakoc D; Yilmaz KB; Hamaloglu E; Esendagli G
Eur J Immunol; 2020 Dec; 50(12):2067-2074. PubMed ID: 32691408
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL.
Ferrer G; Jung B; Chiu PY; Aslam R; Palacios F; Mazzarello AN; Vergani S; Bagnara D; Chen SS; Yancopoulos S; Xochelli A; Yan XJ; Burger JA; Barrientos JC; Kolitz JE; Allen SL; Stamatopoulos K; Rai KR; Sherry B; Chiorazzi N
Leukemia; 2021 Nov; 35(11):3163-3175. PubMed ID: 33935280
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of circulating myeloid-derived suppressor cell subsets: predicting poor clinical efficacy and prognosis through T cell suppression in non-Hodgkin's lymphoma.
Pu LF; Li MM; Feng XJ; Zhang T; Hu LH; Zheng HM; Charwudzi A; Ding YY; Liu J; Liu ZL; Xiong SD
J Leukoc Biol; 2024 May; 115(6):1094-1107. PubMed ID: 38369808
[TBL] [Abstract][Full Text] [Related]
18. Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets.
Tomić S; Joksimović B; Bekić M; Vasiljević M; Milanović M; Čolić M; Vučević D
Front Immunol; 2019; 10():475. PubMed ID: 30936876
[TBL] [Abstract][Full Text] [Related]
19. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
[TBL] [Abstract][Full Text] [Related]
20. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
